Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectivenes of phenylbutyrate in treating adults with refractory
solid tumor or lymphoma. Drugs used in chemotherapy use different ways to stop tumor cells
from dividing so they stop growing or die.